Upgrade to SI Premium - Free Trial

Neogenomics (NEO) PT Raised to $22 at Needham

October 6, 2026 7:11 AM
Needham analyst Mike Matson raised the price target on Neogenomics (NASDAQ: NEO) to $22.00 (from $19.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change